Skip to search formSkip to main contentSkip to account menu

MCI 186

Known as: MCI-186 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Background and Objective: This study aims to evaluate the safety and efficacy of edaravone, a novel free radical scavenger, in a… 
2007
2007
The mechanism by which MCI‐186 (3‐methyl‐1‐phenyl‐2‐prazolin‐5‐one) exerts protective effects during cerebral infarction, other… 
2006
2006
Edaravone (MCI-186) is a novel synthetic free radical scavenger intended to have neuroprotective effect against ischemic insult… 
Highly Cited
2003
Highly Cited
2003
AIM To determine whether ONO-1078 [pranlukast, 4-oxo-8-[p-(4-phenylbutyloxy)benzoyl-amono]-2-(tetrazol-5-yl)-4H-1-benzopyran… 
2002
2002
Summary. Background: Cerebral vasospasm is one of the important pathological phenomena which influence morbidity and mortality… 
2002
2002
Despite growing evidence that reactive oxygen species are responsible for deleterious effects of ischemia-reperfusion (I/R… 
Highly Cited
1996
Highly Cited
1996
MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) is a newly developed antioxidant which has been shown to reduce brain edema in…